Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2002
08/08/2002WO2002031153A3 Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains
08/08/2002WO2002029062A3 Cytokine proteins
08/08/2002WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
08/08/2002WO2002026192A3 Viruses targeted to hypoxic cells and tissues
08/08/2002WO2002024872A3 Manipulation of spermatozoa
08/08/2002WO2002022836A3 A method for producing plants which are resistant to closteroviruses
08/08/2002WO2002020833A3 Method for the specific determination of dna -sequences by means of parallel amplification
08/08/2002WO2002020762A3 Tnf receptor-like molecules and uses thereof
08/08/2002WO2002020572A3 Nucleotide sequences coding for the chrs gene
08/08/2002WO2002020543A3 Synthons for oligonucleotide synthesis
08/08/2002WO2002018582A3 62112, a novel human dehydrogenase and uses thereof
08/08/2002WO2002018556A3 8797, a human galactosyltransferase and uses thereof
08/08/2002WO2002016397A3 Haplotypes of the lipg gene
08/08/2002WO2002014366A3 Genes involved in immune related responses observed with asthma
08/08/2002WO2002012514A3 Jet, an artificial promoter for gene expression
08/08/2002WO2002012513A3 Phage display method
08/08/2002WO2002012293A3 Hypersensitive response elicitor from xanthomonas campestris
08/08/2002WO2002008395A3 Putative human methyltransferase family member and uses thereof
08/08/2002WO2002006318A3 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
08/08/2002WO2002004614A3 Genes encoding sinapoylglucose: malate sinapoyltransferase and methods of use
08/08/2002WO2002002807A3 Diagnosis of diseases associated with cell signalling
08/08/2002WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/08/2002WO2002000885A3 Assembly of wild-type and chimeric influenza virus-like particles (vlps)
08/08/2002WO2002000853A3 Regulation of human caspase-1-like protease
08/08/2002WO2002000840A3 Human lyases
08/08/2002WO2002000695A3 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
08/08/2002WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties
08/08/2002WO2001098455A3 Method for preparing a physiologically active il-18 polypeptide
08/08/2002WO2001098349A3 Recombinant avidin monomer and its use in biotin binding
08/08/2002WO2001096546A3 Protein phosphatases
08/08/2002WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
08/08/2002WO2001094635A9 Integrated active flux microfluidic devices and methods
08/08/2002WO2001092883A3 Surface for the immobilisation of ligands
08/08/2002WO2001092547A3 Modified bovine adenovirus having altered tropism
08/08/2002WO2001092522A3 Human fgf-20 nucleic acids and polypeptides
08/08/2002WO2001092306A3 Therapeutic compounds for ovarian cancer
08/08/2002WO2001092298A9 MUTEINS OF A CHAIN OF A PROTEIN FROM THE SUPERFAMILY OF GROWTH FACTOR TGF-$g(b)
08/08/2002WO2001091536A3 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
08/08/2002WO2001090383A3 Co-expression of recombinant proteins
08/08/2002WO2001090361A3 Modulation of inflammation by protease-treated mcp-3 chemokine
08/08/2002WO2001090330A3 AMINOACYL tRNA SYNTHETASES
08/08/2002WO2001088101A3 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
08/08/2002WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
08/08/2002WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/08/2002WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
08/08/2002WO2001085773A3 Luxo-sigma54 interactions and methods of use
08/08/2002WO2001081598A3 Multiple retrotransposon families in candida albicans
08/08/2002WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec)
08/08/2002WO2001077376A3 Diagnosis of diseases associated with metastasis
08/08/2002WO2001077350A3 Compositions and methods for inhibiting gene expression
08/08/2002WO2001076451A9 Diagnosis of diseases associated with metabolism
08/08/2002WO2001075435A3 Fluorescence assay for gamma-secretase activity and inhibitors
08/08/2002WO2001075171A3 Methods, compositions and kits for the detection and monitoring of breast cancer
08/08/2002WO2001075044A3 A novel polypeptide- human ribosomal protein s18-18 and the polynucleotide encoding said polypeptide
08/08/2002WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
08/08/2002WO2001068117A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
08/08/2002WO2001068116A3 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
08/08/2002WO2001068077A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
08/08/2002WO2001064905A3 2504, 15977, and 14760, novel protein kinase family members and uses therefor
08/08/2002WO2001061001A9 Novel, central nervous protein, that modulates k+ flows
08/08/2002WO2001059152A9 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
08/08/2002WO2001051641A9 Irak-4: compositions and methods of use
08/08/2002WO2001051523A3 Anti-angiogenic proteins and fragments and methods of use thereof
08/08/2002WO2001048238A3 Chemotherapeutant screening method
08/08/2002WO2001046477A9 Multispecies food testing and characterization
08/08/2002WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer
08/08/2002WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1
08/08/2002WO2001031011A9 Gene mining system and method
08/08/2002WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
08/08/2002WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use
08/08/2002WO2001016330A3 Prevention of affections associated with porcine circovirus-2
08/08/2002WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
08/08/2002WO2001009325A9 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations
08/08/2002WO2001008703A9 Recombinant rsv virus expression systems and vaccines
08/08/2002WO2001008636A8 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
08/08/2002WO2001004285A9 Maize msi polynucleotides and methods of use
08/08/2002WO2000074635A3 Delivery of single stranded dna for expression
08/08/2002WO2000073510A9 iETHOD OF TRANSPOSON-MEDIATED MUTAGENESIS IN THE NEMATODE CAENORHABDITIS ELEGANS
08/08/2002WO2000055314A9 Inhibitors of endothelin-1 synthesis
08/08/2002US20020108151 Regulation of quinolate phosphoribosyl transferase expression
08/08/2002US20020108149 Methods of increasing polypeptide accumulation in plants
08/08/2002US20020108148 Nucleic acid sequences to proteins involved in isoprenoid synthesis
08/08/2002US20020108147 Nucleotide sequences coding enzymatic polypeptide for use in the generation of gamma linolenic acid
08/08/2002US20020108146 Expression vector for use in the generation of disease resistant plants
08/08/2002US20020108145 Polypeptide for use in inducing diseases resistance in plants
08/08/2002US20020108143 Theobromine synthase polypeptide of coffee plant and the gene encoding said polypeptide
08/08/2002US20020108142 Application of bi-directional promoters for modification of gene expression
08/08/2002US20020108141 Promoter element leads to the expression of desired genes in all plant tissues; use in transgenic plants
08/08/2002US20020108140 Compositions and methods for enhancing disease resistance in plants
08/08/2002US20020108139 Production of a plant resistant to low temperatures
08/08/2002US20020108138 Plasmid for use in animal model which evaluate, diagnose and treat, splen, kidney, liver, thymus, lymph nodes and bone disorders
08/08/2002US20020108137 Nucleotide sequences coding preferential polypeptide for use in gene and tumor therapy
08/08/2002US20020108136 Animal models for use as tools in the treatment of genetic disorders
08/08/2002US20020108134 HS-40 enhancer-containing vector
08/08/2002US20020108132 Production of a monoclonal antibody by a transgenic chicken
08/08/2002US20020108131 Screening drugs for use in treatment of heart defects and stroke; obtain animal, incubate with drug, monitor animal for adjustment in phenotype
08/08/2002US20020108130 Extracellular drug-oligonucleotides chimeric molecules
08/08/2002US20020107869 Novel implant and novel vector for the treatment of acquired diseases
08/08/2002US20020107387 Nucleotide sequences coding envelope protein for use in prevention of viral disease and parasitic infections
08/08/2002US20020107385 Human breast tumor-specific proteins
1 ... 2742 2743 2744 2745 2746 2747 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 ... 4023